Indeed, while Nrf2 activation increases in some conditions associated with oxidative stress, such as neurodegenerative diseases, COPD, and aging [50], suppression of this pathway can be observed in diseases characterized by recurrent, acute, and predominantly neuroinflammatory stress, such as migraine. The gene discussed is NFE2L2; the disease is neurodegenerative disease.